Sources | Names Used |
---|---|
CTRPv2 | 16-beta-bromoandrosterone |
PharmacoGx | 16-beta-bromoandrosterone |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RAB3D | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
mRNA | DLL1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | DACH2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | ENTPD2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | PRDM15 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | TIA1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | MDH1B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | NDUFAF6 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | HCN4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | RP11-96L14.8 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |